Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients

AIMS: Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor prognosis, especially in acute decompensated HF. However, there are no data on chronic HF patients. The aim is...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcondes‐Braga, Fabiana G., Gioli‐Pereira, Luciana, Bernardez‐Pereira, Sabrina, Batista, Guilherme L., Mangini, Sandrigo, Issa, Victor S., Fernandes, Fabio, Bocchi, Edimar A., Ayub‐Ferreira, Silvia M., Mansur, Alfredo J., Gutz, Ivano G.R., Krieger, Jose E., Pereira, Alexandre C., Bacal, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373929/
https://www.ncbi.nlm.nih.gov/pubmed/32383349
http://dx.doi.org/10.1002/ehf2.12736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373929/
https://www.ncbi.nlm.nih.gov/pubmed/32383349
http://dx.doi.org/10.1002/ehf2.12736

Ejemplares similares